| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.34 | 0.003 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.67 | 0.009 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |